Food and Drug Administration (FDA) has determined there is a safety risk if the shape and size of a generic drug is not similar to its reference drug. FDA made suggestions in a guidance last week calling for the original pill and capsules and its generic form to be similar in order to provide safety for patient use. It has been found that the size and shape of the capsule can affect the person’s ability to swallow.

To find out more on the argument of size and shape of the generic pill, click here.

Want to know about the latest FDA guidance’s? Our staff can help. Email us at